Adam Elisha, D.O. is currently a senior internal medicine resident physician in Spokane, WA.
Dr. Elisha attended the University of Toronto in Toronto, Ontario for his undergraduate education. Dr. Elisha majored in neuroscience and political science. He was awarded an Honors Bachelor of Science (H.B.Sc) degree as well as Dean's List distinction.
Before attending medical school, Dr. Elisha spent two years teaching physics to underserved teenagers in downtown Toronto, Ontario.
Dr. Elisha attended Midwestern University (Arizona College of Osteopathic Medicine) for his medical education. Upon completing medical school, Dr. Elisha continued his medical training as an internal medicine resident in Spokane, Washington at Providence Sacred Heart Medical Center, a University of Washington affiliate program.
Dr. Elisha is passionate about preventative health care and assisting his patients achieve both short and long term optimization of their health and well-being. Dr. Adam Elisha is a member of the American College of Physicians (ACP) and the American College of Rheumatology (ACR). His current academic interests include hospital medicine and spondyloarthropy research, particularly novel therapeutics.
Further, Dr. Elisha has a strong interest in addiction medicine and harm reduction approaches to combat the growing opioid epidemic in the United States. He recently completed additional training and received certification from the Substance Abuse and Mental Health Services Administration (SAMHSA) and is now authorized to prescribe bupenorphine for medication assisted treatment (MAT) for those suffering from opioid addiction.
Adam Elisha will be completing his residency in internal medicine in June 2017. Dr. Elisha plans to pursue a position in hospital medicine to further broaden his knowledge base and skill set in internal medicine. Simultaneously, Dr. Elisha looks forward to completing rheumatologic research, again with a focus on novel therapeutic agents in the management of spondyloarthropies.
He looks forward to pursuing a fellowship in rheumatology in the future.